Thu, July 27, 2017
Wed, July 26, 2017
Tue, July 25, 2017

Matthew Harrison Maintained (BIIB) at Hold with Increased Target to $311 on, Jul 26th, 2017

Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Hold with Increased Target from $301 to $311 on, Jul 26th, 2017.

Matthew has made no other calls on BIIB in the last 4 months.



There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Eun Yang of "Jefferies" Initiated at Hold and Held Target at $310 on, Tuesday, July 11th, 2017


This is the rating of the analyst that currently disagrees with Matthew


  • Andrew Peters of "Deutsche Bank" Initiated at Strong Buy and Held Target at $315 on, Friday, June 23rd, 2017